eprova® Drug Delivery Compounds & Services

Higher bioavailability

Drug delivery compounds can improve the chemical stability and solubility of your biopharmaceuticals. Merck’s highly efficient eprova^® drug delivery compounds in cGMP quality can greatly enhance the efficacy of an active ingredient.

eprova^® drug delivery compounds & services adds value to your business

Our cGMP drug delivery compounds are suitable for clinical trials and commercial product applications. Quality is not only a catchword for us: it is our duty. Our outstanding cGMP track record is proven by numerous audits by customers as well as health authorities. Only endotoxin-controlled highly purified water, complying with Ph. Eur. 01-2005:1927 is used at the production site of Merck & Cie in Schaffhausen, Switzerland. Because of these cornerstones, we offer you consistent quality and stable products.

Our analytical service ranges comprise development and validation of analytical and microbiological methods, identification of by-products and determination of polymorphic forms, but also stability studies according to ICH and determination of bioburden and endotoxin content. Merck’s broad portfolio of analytical measurement methods includes HPLC (/MS), CE, GC (/MS), FT-IR, NMR, XRD, DSC, ICP, particle size determination, and many more.

As eprova^® drug delivery compounds & services we provide regulatory support such as preparation of a CTD for DMF filings.

Tailor-made drug delivery compounds for you

Merck’s eprova^® drug delivery compounds & services provide custom-made solutions: Starting from route finding or improvement of an existing process, we synthesize by-products, develop and validate analytical methods and source for suitable raw materials. From small quantities, we scale up the processes and transfer them to full-scale production and, of course, we validate production processes.